换一批
换一批Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.
作者：
Kieren D,Marini [1]
;
David R,Croucher [2]
;
Rachael A,McCloy [3]
;
Vijesh,Vaghjiani [4]
;
Alvaro,Gonzalez-Rajal [5]
;
Jordan F,Hastings [3]
;
Venessa,Chin [1]
;
Anette,Szczepny [3]
;
Kaja,Kostyrko [3]
;
Cesar,Marquez [3]
;
W Samantha N,Jayasekara [6]
;
Muhammad,Alamgeer [1]
;
Vishal,Boolell [7]
;
Jeremy Z R,Han [7]
;
Todd,Waugh [1]
;
Hong Ching,Lee [1]
;
Samantha R,Oakes [2]
;
Beena,Kumar [8]
;
Craig A,Harrison [1]
;
Mark P,Hedger [8]
;
Nirmal,Lorensuhewa [3]
;
Badia,Kita [1]
;
Ross,Barrow [3]
;
Bruce W,Robinson [3]
;
David M,de Kretser [4]
;
Jianmin,Wu [9]
;
Vinod,Ganju [1]
;
E Alejandro,Sweet-Cordero [2]
;
Andrew,Burgess [1]
;
Luciano G,Martelotto [2]
;
Fernando J,Rossello [10]
;
Jason E,Cain [10]
;
D Neil,Watkins [10]
作者单位：
Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
[1]
Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3800, Australia.
[2]
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia.
[3]
St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Darlinghurst, New South Wales 2010, Australia.
[4]
School of Medicine, University College Dublin, Belfield, Dublin D04 V1W8, Ireland.
[5]
Department of Medical Oncology, St. Vincent's Hospital, Darlinghurst, New South Wales 2010, Australia.
[6]
Department of Pediatrics, University of California San Francisco, San Francisco, CA 94158, USA.
[7]
Department of Medical Oncology, Monash Medical Centre, East Bentleigh, Victoria 3165, Australia.
[8]
Department of Pathology, Monash Medical Centre, Clayton, Victoria 3168, Australia.
[9]
Paranta Biosciences Limited, Melbourne, Victoria 3004, Australia.
[10]
School of Medicine and Pharmacology, Queen Elizabeth II Medical Centre Unit, University of Western Australia, Crawley, Western Australia 6009, Australia.
[11]
Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing, China.
[12]
Center for Cancer Bioinformatics, Peking University Cancer Hospital and Institute, Hai-Dian District, Beijing 100142, China.
[13]
ANZAC Research Institute, Concord, New South Wales 2139, Australia.
[14]
Center for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria 3000, Australia.
[15]
Australian Regenerative Medicine Institute, Clayton, Victoria 3800, Australia.
[16]
Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia.
[17]
Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia. n.watkins@garvan.org.au jason.cain@hudson.org.au.
[18]
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia. n.watkins@garvan.org.au jason.cain@hudson.org.au.
[19]
Department of Thoracic Medicine, St. Vincent's Hospital, Darlinghurst, New South Wales 2010, Australia.
[20]
主题词
激活素类(Activins);动物(Animals);卡铂(Carboplatin);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);卵泡抑素(Follistatin);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);小鼠(Mice);铂(Platinum);信号传导(Signal Transduction);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1126/scitranslmed.aat3504
PMID
30045976
发布时间
2019-10-07
- 浏览12
Science translational medicine
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
